• Deep Learning-Based Cardiotoxicity Detection in iPSC-CMs

  2026-04-21

  This study presents a scalable platform using deep learning and high-content imaging to rapidly identify cardiotoxic compounds in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). By integrating phenotypic screening with advanced computational methods, the research addresses key barriers in early-stage drug safety assessment and highlights translational tools to streamline cardiac electrophysiology research.

• Rotigotine as a Dopaminergic Modulator: Mechanistic Insights

  2026-04-20

  Explore how Rotigotine, a potent dopamine D2/D3 receptor agonist, advances neuropsychiatric research by bridging Parkinson’s disease and depression models. This article delivers a mechanistic deep-dive and practical assay recommendations, setting it apart from standard protocol guides.

• Vernakalant Hydrochloride: Precision Workflows for Rapid AF

  2026-04-20

  Vernakalant Hydrochloride (RSD1235) delivers atrial-selective antiarrhythmic action, enabling rapid conversion of atrial fibrillation with minimal ventricular risk. This article distills advanced experimental workflows, troubleshooting insights, and comparative guidance for leveraging Vernakalant Hydrochloride in both in vitro and in vivo AF research.

• Pharmacokinetic Variability of CSBTA in MASH: New Insights f

  2026-04-19

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By mapping the interplay between pathological status, metabolic enzymes, and transporters, the research offers valuable guidance for optimizing therapeutic regimens in MASH and related metabolic liver diseases.

• TPPU in sEH Inhibition: Precision, Protocols, and the Nrf2 A

  2026-04-18

  Explore the unique role of TPPU as a potent soluble epoxide hydrolase inhibitor, with a focus on its mechanistic impact on the Nrf2 pathway and bone-immune crosstalk. This article delivers practical assay guidance and protocol insights distinct from existing resources.

• Dissecting Drug Response in Cancer: Fractional vs. Relative

  2026-04-17

  Schwartz's dissertation advances in vitro cancer drug evaluation by rigorously distinguishing proliferative arrest from cell death using dual metrics—fractional and relative viability. This nuanced approach clarifies drug mechanisms and supports more reproducible apoptosis induction assays, directly informing systems pharmacology and translational research.

• Kir2.1 Inhibition Suppresses PASMC Proliferation and Migrati

  2026-04-16

  This study demonstrates that inhibition of the Kir2.1 potassium channel reduces pulmonary artery smooth muscle cell (PASMC) proliferation and migration, key drivers of pulmonary vascular remodeling in pulmonary hypertension. The research illuminates Kir2.1's regulatory role via the TGF-β1/SMAD2/3 pathway, offering mechanistic insights relevant for targeted cardiovascular modeling.

• Ginsenoside Rg1 Restores Gut-Brain-Immune Balance After Anes

  2026-04-15

  A recent study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neurobehavioral and neuroimmune deficits induced by prolonged isoflurane anesthesia in mice. The findings highlight a Treg-dependent mechanism linking gut barrier integrity, systemic inflammation, and hippocampal function, offering new insight for neuroprotection research.

• Propranolol: Applied Use in Cardiovascular and Memory Resear

  2026-04-14

  Propranolol, a non-selective β-adrenergic receptor blocker, enables precise modulation of cardiovascular and neurobehavioral pathways in translational research. This article details hands-on workflows, protocol refinements, and troubleshooting strategies, leveraging APExBIO’s high-purity Propranolol for reproducible results in both in vitro and in vivo models.

• Lamotrigine in CNS Research: Workflow Optimization & BBB Mod

  2026-04-13

  Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is a gold standard for sodium channel and serotonin pathway interrogation in cutting-edge CNS and cardiac research. Discover how high-purity Lamotrigine from APExBIO enables robust blood-brain barrier workflows, advanced epilepsy-induced arrhythmia modeling, and troubleshooting strategies for translational assay success.

• Indomethacin for Inflammation and Lipid Metabolism Research

  2026-04-13

  Indomethacin, a potent nonsteroidal anti-inflammatory drug, is redefining experimental strategies in inflammation and lipid metabolism research. Here, we dissect advanced workflows and troubleshooting insights, spotlighting its role in adipocyte differentiation studies and membrane signaling modulation.

• ABT-263 (Navitoclax): Advancing Apoptosis Assays in Cancer B

  2026-04-12

  ABT-263 (Navitoclax) empowers researchers to unravel apoptotic mechanisms in cancer models, with exceptional potency against Bcl-2 family proteins. This article delivers protocol upgrades, troubleshooting tactics, and cross-study insights to optimize your caspase-dependent apoptosis research.

• Vardenafil HCl Trihydrate: Proteoform Precision in PDE5 Rese

  2026-04-12

  This thought-leadership article explores how Vardenafil HCl Trihydrate empowers translational researchers to dissect proteoform-specific cGMP signaling and smooth muscle relaxation with unprecedented mechanistic resolution. Integrating advanced findings from native mass spectrometry and recent proteomics, we outline how this selective PDE5 inhibitor advances beyond traditional approaches—delivering strategic guidance for the next generation of PDE5 inhibition assays and translational models.

• Filipin III: Optimized Cholesterol Detection in Membranes

  2026-04-11

  Filipin III, the predominant polyene macrolide antibiotic isomer, enables precise cholesterol detection in membrane microdomains, underpinning advanced applications from immunometabolic research to high-resolution imaging. This guide details proven workflows, troubleshooting strategies, and protocol enhancements that leverage APExBIO's Filipin III for robust, reproducible results.

• Firefly Luciferase mRNA: Optimizing Delivery & Translation w

  2026-04-11

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) from APExBIO elevates mRNA delivery and translation efficiency assays by combining enhanced expression, immune evasion, and superior stability. This guide details practical workflows, integration with cutting-edge nanoparticle delivery, and actionable troubleshooting for robust bioluminescent readouts.

11450 records 6/764 page Previous Next First page 上5页 678910 下5页 Last page